Welcome to NDF Research
  • Introducing NDF
  • About us
    • About our Senior Analyst
    • Disclaimer relating to research and web content
    • Financial Services Guide and General Advice Warning
  • What we do
    • The Rise of the New Analysts
    • MiFID II
  • Our sector
    • ASX-Listed Life Science companies we watch >
      • ASX-listed Life Science companies, >$200m
      • ASX-listed Life Science companies, $100-200m
    • About Australia and Australians
    • Australia and the Life Sciences
    • Life Sciences in New Zealand >
      • Building the New Zealand Life Sciences sector
    • A tour of Life Sciences Down Under
    • Australia's global competitiveness in Life Sciences >
      • Australia's Life Sciences Innovation Rating
      • Australia's Life Sciences clusters
      • Australia's World-Class Universities
      • Australia's Nobel Laureates
      • Australia's public policy support for Life Sciences
      • Australia's support for women in Life Sciences
    • The Coming Boom in Australian Life Sciences >
      • Welcome to Australia's Life Sciences Boom
    • Key organisations in the Life Science sector in Australia and New Zealand
    • Notable people in the Life Sciences sector in Australia and New Zealand >
      • Great CEOs
      • 2017 Red Hat Award Winners
      • 2018 Red Hat Award Winners
      • 2019 Red Hat Award Winners
    • The NDF Life Sciences Index >
      • 2016-2017 Year in Review
  • Our clients
  • Contact us
    • linkedin
    • Twitter
    • NDF Research Youtube Channel
  • Latest research
    • Comprehensive update reports
    • Shorter update reports
    • Initiation reports >
      • Admedus
      • Invion
    • Media and interviews
    • Presentations
    • Previous research and media, 2003-2015
    • A Brief History of the Life Sciences in Australia
    • In our library
    • Intellectual property >
      • Australian PCT patent applications
      • New Zealand PCT patent applications
      • PCT patent applications, last twelve months >
        • 2017 PCT patent applications
        • 2016 PCT patent applications
        • 2015 PCT patent applications
        • 2014 PCT patent applications
        • 2013 PCT patent applications
      • US patents >
        • 2017 US patents
        • 2016 US patents
        • 2015 US patents
        • 2014 US patents
    • Publications
    • Glossary
    • Global Life Science companies to watch
  • Blog
US Life Science patents to Australian assignees, last twelve months
By Stuart Roberts, Senior Analyst, stuart@ndfresearch.com, +61 447 247 909
The US Patent Office issues new patents every Tuesday. Australian assignees generally get two or three healthcare and biotech-related patents a week. Here are the 109 US patents relevant to Australia's Life Sciences sector that have issued since 29 December 2015, for an issuance rate of 2.1  per week.

US Patent 9,527,908

Title: ​Modified variable domain molecules and methods for producing them
Issued: 27 December 2016
Assignee: Garvan Institute of Medical Research
Description: This patent antibody variable domains with aggregation-resistance properties.

US Patent 9,526,734

Title: ​Formulation of meloxicam
Issued: 27 December 2016
Assignee:iCeutica
Description: This patent covers a dry-milled nanoparticle formulation of meloxicam.

US Patent 9,522,214

Title: ​Viscous haemostatic compositions and method of treatment 
Issued: 20 December 2016
Assignee: Eupharma
Description: This patent covers blood clotting drugs formulated as viscous thixotropic compositions.

US Patent 9,518,127

Title: ​Inhibitory anti-factor XII/XIIA monoclonal antibodies and their uses
Issued: 13 December 2016
Assignee: CSL Ltd
Description: This patent covers antibodies useful as anticoagulants.

US Patent 9,518,109

Title: ​Prevention, treatment and diagnosis of P. gingivalis infection
Issued: 13 December 2016
Assignee: Oral Health Australia Pty Ltd
Description: This patent covers a vaccine against Porphyromonas gingivalis.

US Patent 9,518,089

Title: ​Metallothionein-derived peptide fragments
Issued: 13 December 2016
Assignee: University of Tasmania
Description: This patent covers eptide fragments derived from metallothioneins that promote neuroregeneration.

US Patent 9,511,080

Title: ​Okadaella gastrococcus and cancer
Issued: 6 December 2016
Assignee: Takayuki Okada
Description: This patent covers treatments related to Okadaella gastrococcus bacterial infection

US Patent 9,511,031

Title: ​Controlled release doxycycline
Issued: 6 December 2016
Assignee: Mayne Pharma
Description: This patent covers Mayne's controlled release formulation of doxycycline.

US Patent 9,511,017

Title: ​Method and composition for use in preparation of a patient for surgery
Issued: 6 December 2016
Assignee: Novapharm Research (Australia) Pty Ltd
Description: This patent covers a transdermal biocide formulation.

US Patent 9,498,525

Title: ​Treatment or prophylaxis of asthma
Issued: 22 November 2016
Assignee: Hunter Immunology
Description: This patent covers the use of killed Haemophilus influenzae in the treatment of asthma.

US Patent 9,492,552

Title: ​Injectable aqueous pharmaceutical compositions comprising a cyclodextrin, a hydrophobic drug, a co-solvent, and a preservative
Issued: 15 November 2016
Assignee: Jurox Pty Ltd
Description: This patent covers a use of cyclodextrins to increase the solubility of drugs.

US Patent 9,492,547

Title: ​Polymorphic form of inulin and uses thereof
Issued: 15 November 2016
Assignee: Vaxine Pty Ltd
Description: This patent covers a new form of the polysaccharide inulin useful as a vaccine adjuvant.

US Patent 9,486,497

Title: ​Treatment of immunocompromised conditions
Issued: 8 November 2016
Assignee: University of Queensland
Description: This patent covers the use of an E-selectin antagonist to treat  hematopoietic disorders such as neutropenia.

US Patent 9,480,717

Title: ​Composition of whey growth factor extract for reducing muscle inflammation
Issued: 1 November 2016
Assignee: Murray Goulburn Co-Operative
Description: This patent covers whey growth factor extract as an anti-inflammatory

US Patent 9,474,789

Title: ​Methods and compositions for promoting organ growth and development
Issued: 25 October 2016
Assignee: Kintan Pty Ltd
Description: This patent covers the use of colony stimulating factor-1 protein (CSF-1) in promoting growth in premature-birthed warm blooded animals.

US Patent 9,474,270

Title: ​Methods and compositions for controlling pests
Issued: 4 October 2016
Assignee: Bioprospect and University of Western Sydney
Description: This patent covers extracts from Eucalyptus cloeziana, commonly known as Gympie Messmate, useful in pest control.

US Patent 9,458,093

Title: ​Compositions for the treatment of hypertension and/or fibrosis​
Issued: 4 October 2016
Assignee: Vectus Biosystems (ASX: VBS)
Description:  This patent covers the use of vasoactive intestinal peptide (VIP) fragment in treating fibrosis and hypertension. 

US Patent 9,457,107

​Title: Cage amine ligands for metallo-radiopharmaceuticals
Issued:  4 October 2016
Assignee: ​University of Melbourne
Description:   This patent covers metal-binding organic compounds that could be useful in radiotherapy.

US Patent 9,457,062

​Title: Chaperonin 10-induced immunomodulation
Issued:  4 October 2016
Assignee: ​​ Invion (ASX: IVX)
Description:  This patent covers chaperonin 10 polypeptides, useful for activating Toll-Like Receptors.

US Patent 9,452,148

​Title: Insulin sensitisers and methods of treatment
Issued: 27 September 2016
Assignee:  Verva Pharmaceuticals
Description:  This patent covers carbonic anhydrase inhibitors for the treatment of insulin resistance.

US Patent 9,452,037

Title: Delivery of oral care products 
Issued: 27 September 2016
Assignee:  OBJ Ltd (ASX: OBJ)
Description:  This patent covers methods to deliver oral care products via magnetic disruption of the tissue barrier.

US Patent 9,447,080

Title: Viral polymerase inhibitors
Issued: 20 September 2016
Assignee:  Biota
Description:  This patent covers small molecule inhibitors to the polymerase enzyme of Hepatitis C Virus​.

US Patent 9,446,057

Title: Controlled release doxycycline. ​
Issued: 20 September 2016
Assignee:  Mayne Pharma (ASX: MYX)
Description:  This patent covers Mayne's controlled release formulation of doxycycline.

US Patent 9,441,239

Title: Methods and means for obtaining modified phenotypes
Issued: 13 September 2016
Assignee: Commonwealth Scientific and Industrial Research Organisation
Description:  This patent covers the CSIRO's gene silencing technology, which involves double-stranded RNA.

US Patent 9,440,926

Title: Antiviral compounds and methods 
Issued: 13 September 2016
Assignee: Biotron (ASX: BIT)
Description: This patent covers antiviral compounds that target the p7 protein of HCV.

US Patent 9,439,946

Title: Reconstituted high density lipoprotein formulation and production method thereof
Issued: 13 September 2016
Assignee: CSL Ltd (ASX: CSL)
Description: This patent covers CSL's reconstituted HDL, useful for the treatment of Acute Coronary Syndrome.

US Patent 9,433,805

Title: Method for dermal regeneration by administering an ether cross-linked glucomannan/hyaluronic acid composition
Issued: 6 September 2016
Assignee: Ultraceuticals
Description: This patent covers the use of glucomannan as a skin care product.

US Patent 9,428,587

Title: Antibodies to non-functional oligomeric P2X7 receptors and methods of use thereof
Issued: 30 August 2016
Assignee: Biosceptre International
Description: This patent covers antibodies to P2X7 receptors which, when expressed on cells without their usual function ion channel function, is indicative of cancer cells.

US Patent 9,427,443

Title: Anaesthetic composition
Issued: 30 August 2016
Assignee: Jurox Pty Ltd
Description: This patent covers a formulation of the anesthetic alfaxalone that can be administered parenterally without invoking a histamine response.

US Patent 9,422,522

Title: Method of producing adipocytes from fibroblast cells
Issued: 23 August 2016
Assignee: Regenertech Pty Ltd (Dr Vishal Bhasin)
Description: This patent covers a formulation which will prompt fibroblasts to differentiate into adipocytes.

US Patent 9,421,205

Title: FAK inhibitors
Issued: 23 August 2016
Assignee: Cancer Therapeutics CRC 
Description: This patent small molecule inhibitors of cancer target Focal Adhesion Kinase.

US Patent 9,415,063

Title: Treatment of neurological disorders
Issued: 16 August 2016
Assignee: Velacor Therapeutics
Description: This patent covers a selenium formulation for the treatment of ​various brain disorders.

US Patent 9,408,919

Title: Biodegradable polymer-bioactive moiety conjugates​
Issued: 9 August 2016
Assignee: PolyActiva Pty Ltd
Description: This patent covers a drug-polymer conjugate with a better release profile than competing drug delivery polymers.

US Patent 9,408,824

Title: Compositions and products containing S-equol, and methods for their making​
Issued: 9 August 2016
Assignee: Sanitarium (50%); Cincinnati Children's Hospital​ (United States, 50%)
Description: This patent covers S-equol, an intestinally derived metabolite of the soy isoflavone daidzein. S-equol may be useful in enhancing the efficacy of soy diets. 

US Patent 9,402,902

Title: Composition and method for the treatment and prevention of enteric bacterial infections​
Issued: 2 August 2016
Assignee: Immuron (ASX: IMC)
Description: This patent a vaccine for Gram negative bacteria made from cell wall antigens.

US Patent 9,402,896

Title: Method of inducing tolerance to an allergen​
Issued: 2 August 2016
Assignee: Murdoch Childrens Research Institute
Description: This patent covers the use of probiotics in the use of oral immunotherapy for peanut allergies.

US Patent 9,394,393

Title: Method for improving the stability of purified factor VIII after reconstitution​
Issued: 19 July 2016
Assignee: CSL Ltd (ASX: CSL)
Description: This patent covers a Factor VIII molecule modified for improved stability by the inactivation of various proteolytic cleavage sites.

US Patent 9,393,287

Title: Methods and compositions for promoting organ development​
Issued: 19 July 2016
Assignee: Kintan Pty Ltd
Description: This patent covers the use of colony stimulating factor-1 protein (CSF-1) in promoting growth in premature-birthed warm blooded animals.  

US Patent 9,393,274

Title: Control of sucking lice​
Issued: 19 July 2016
Assignee: Dudley Pinnock and David Cooper
Description: This patent covers the use of mixtures of Bacillus thuringiensis and related bacteria in the treatment of lice infestations in sheep.

US Patent 9,387,218

Title: Composition for the treatment of inflammatory and immune disorders​
Issued: 12 July 2016
Assignee: Eaglepharma Pty Ltd (Paul Turner)
Description: This patent covers an anti-inflammatory formulation of methylsulphonylmethane and glucosamine.

US Patent 9,387,213

Title: Small molecules inhibiting oncoprotein Myc​
Issued: 12 July 2016
Assignee: Panacela Labs (part owned by Children's Cancer Institute Australia)
Description: This patent covers a Myc inhibitor.

US Patent 9,381,262

Title: Methods for radiolabeling synthetic polymers
Issued:
 5 July 2016
Assignee: Australian National University
Description: This patent covers a radiolabeled polymer useful in brachytherapy.

US Patent 9,381,240

Title: Recombinant low virulence bovine herpesvirus-1 (BoHV-1) vaccine vectors
Issued: 5 July 2016
Assignee: The Queensland Department of Agriculture and Fisheries (50%) and Meat & Livestock Australia (50%)
Description: This patent covers a bovine viral diarrhea virus​.

US Patent 9,376,682

Title: Method of treating pulmonary disease by administering an antibody to G-CSF
Issued: 28 June 2016
Assignee: CSL Ltd (ASX: CSL)
Description: This patent covers an antibody to G-CSF, useful for treating the ​neutrophil infiltration associated with COPD.

US Patent 9,365,829

Title: Cells genetically modified to comprise pancreatic islet glucokinase and uses thereof
Issued: 14 June 2016
Assignee: University of Technology, Sydney
Description: This patent covers a technology to engineer insulin-secreting human liver cell line.

US Patent 9,365,650

Title: Single chain antibodies that specifically bind to the activated state of the platelet integrin receptor GP IIb/IIIa
Issued: 14 June 2016
Assignee: Baker IDI Heart and Diabetes Institute
Description: This patent covers an antibody-based anticoagulant agent.

US Patent 9,364,570

Title: Functionalisation of cage amine ligands for metallo-radiopharmaceuticals
Issued: 14 June 2016
Assignee: University of Melbourne
Description: This patent covers metal-binding organic compounds that could be useful in radiotherapy.

US Patent 9,364,534

Title:  Treatment of neurological conditions
Issued: 14 June 2016
Assignee: CSL Ltd (ASX: CSL)
Description: This patent covers the use of anti-GSF receptor antibodies in the treatment of Multiple Sclerosis.  

US Patent 9,359,422

Title: Single chain relaxin polypeptides
Issued: 7 June 2016
Assignee: University of Queensland (50%), Florey Institute of Neuroscience and Mental Health (50%)
Description: This patent covers analogues of relaxin-3, potentially useful in the treatment of addictions.

US Patent 9,359,377

Title: Substituted imidazo[1,2-a]imidazo[4',5':4,5]pyrrolo[1,2-d]pyrazines for treating respiratory syncytial virus infections
Issued: 7 June 2016
Assignee: Biota
Description: This patent covers direct-acting anti-virals for Respiratory Syncytial Virus.

​US Patent 9,358,247

Title: Methods and compositions for promoting activity of anti-cancer therapies
Issued: 7 June 2016
Assignee: ORIL
Description: This patent covers the use of saponins in the treatment of cancer.

US Patent 9,353,152

Title: Induction of the mitochondrial permeability transition
Issued: 31 May 2016
Assignee: University of New South Wales
Description: This patent covers methods to identify compounds which will induce apoptosis in cancer cells through breaking open the inner mitochondrial membrane.

US Patent 9,352,038

Title: Treatment of neurological conditions
Issued: 31 May 2016
Assignee: ​CSL Ltd (ASX: CSL)
Description: This patent covers the use of anti-GSF receptor antibodies in the treatment of Multiple Sclerosis. 

US Patent 9,352,034

Title: Methods of treating pain using an antibody specific for GM-CSF
Issued: 31 May 2016
Assignee: University of Melbourne
Description: This patent covers antibodies to GM-CSF in the treatment of pain.

US Patent 9,351,977

Title: Methods of reducing mammographic breast density and/or breast cancer risk
Issued: 31 May 2016
Assignee: Chavah Pty Ltd 
Description: This patent covers the use of testosterone and anastrozole to reduce mammographic breast density, improving the ability to detect breast cancer with mammograms.

US Patent 9,345,911

 Title: Methods of inducing melanogenesis in a subject
Issued: 24 May 2016
Assignee: Clinuvel Pharmaceuticals (ASX: CUV)
Description: This patent covers the use of alpha-MSH analogues to induce melanogenesis.

US Patent 9,345,667

Title: Particles having hydrophobic material therein
Issued: 24 May 2016
Assignee: ​Australian Nuclear Science & Technology Organisation
Description: This patent covers a method for packaging hydrophobic molecules for timed delivery.

US Patent 9,340,622

Title: Synthetic immunogen useful for generating long lasting immunity and protection against pathogens
Issued:
 17 May 2016
Assignee: University of Melbourne (50%), ​Council of Scientific and Industrial Research (India, 50%)
Description: This patent covers a tuberculosis peptide vaccine which combines promiscuous epitopes from M. tuberculosis linked to a TLR ligand.

US Patent 9,340,583

Title: VIP fragments and methods of use
Issued: 17 May 2016
Assignee: ​Vectus Biosystems (ASX: VBS)
Description: This patent covers the use of vasoactive intestinal peptide (VIP) fragment in treating fibrosis and hypertension. 

US Patent 9,340,517

Title: Methods of modulating the activity of the MC5 receptor and treatment of conditions related to this receptor
Issued:
 17 May 2016
Assignee:  Mimetica Pty Ltd
Description: This patent covers small molecules to modulate the melanocortin-5 receptor, useful in the treatment of skin disorders.

US Patent 9,326,539

Title: Compositions comprising dietary fat complexers and methods for their use​
Issued: 3 May 2016
Assignee:  Soho Flordis International
Description: This patent covers alpha-cyclodextrin, which as a food ingredient can prevents fat absorption.

US Patent 9,320,755

Title: Therapeutic and diagnostic molecules
Issued: 26 April 2016
Assignee: Centenary Institute (33%), University of Sydney (33%) Wenkart Foundation (33%)
Description: This patent covers an anti-angiogenesis microRNA.

US Patent 9,315,581

Title: Immuno-conjugates and methods for producing them
Issued: 19 April 2016
Assignee: Avipep Pty Ltd
Description: This patent covers binding sites on antibodies for antibody-drug-conjugates.

US Patent 9,314,527

Title: Transdermal delivery patch
Issued: 19 April 2016
Assignee: Phosphagenics (ASX: POH)
Description: This patent covers a Vitamin E-based transdermal drug delivery system inside a polymer carrier.

US Patent 9,314,450

Title: Combination therapy
Issued: 19 April 2016
Assignee: Dimerix (ASX: DXB)
Description: This patent covers the combination of irbesartan and propagermanium in the treatment of kidney disease.

US Patent 9,308,193

Title: Kinase inhibitors for the treatment of cancer
Issued: 12 April 2016
Assignee: ​PharmAust (ASX: PAA)
Description: This patent covers the use of the anthelmintic agent Monepantel in the treatment of cancer.

US Patent 9,303,026

Title: Antiviral agents
Issued: 5 April 2016
Assignee: Biota
Description: This patent covers small molecules for the treatment of picornavirus infections.

US Patent 9,302,993

Title: 8-hydroxy quinoline derivatives
Issued: 5 April 2016
Assignee: Prana Biotechnology (ASX: PBT)
Description: This patent covers a suite of metal-protein attenuating compounds useful in treating Alzheimer's.

US Patent 9,299,476

Title: Polymeric material
Issued: 29 March 2016
Assignee: University of New South Wales
Description: This patent covers conductive polymer, useful as an interface between a metal electrode and biological tissue.

US Patent 9,295,654

Title: Layered nanoparticles
Issued: 29 March 2016
Assignee: ​Australian Nuclear Science & Technology Organisation
Description: This patent covers core-shell ceramic nanoparticles for drug delivery.

US Patent 9,295,652

Title: Controlled release doxycycline
Issued: 29 March 2016
Assignee: Mayne Pharma (ASX: MYX)
Description: This patent covers an enteric-coated doxycycline formulation.

US Patent 9,295,628

Title: Stabilized calcium phosphate complexes
Issued: 29 March 2016
Assignee: University of Melbourne
Description: This patent covers casein phosphopeptide formulations used for the prevention of tooth decay.

US Patent 9,290,577

Title: Immuno-conjugates and methods for producing them
Issued: 22 March 2016
Assignee: Avipep Pty Ltd
Description: This patent covers antibody-drug conjugates.

US Patent 9,289,586

Title: Spreading implement
Issued: 22 March 2016
Assignee: Acrux (ASX: ACR)
Description: This patent covers a delivery device for transdermally-delivered drugs.

US Patent 9,289,410

Title: Tiglien-3-one derivatives
Issued: 22 March 2016
Assignee: QBiotics
Description: This patent covers an anti-cancer agents derived from the blushwood tree (Hylandia Dockrillii).

US Patent 9,289,381

Title: Stabilization and storage of biological pharmaceutical compositions
Issued: 22 March 2016
Assignee: Monash University (33%), The University of North Carolina at Charlotte (US, 33%),  Charlotte-Mecklenburg Hospital Authority (US, 33%) 
Description: This patent covers a liquid called choline dihydrogen phosphate for the delivery of recombinant human interleukin-2. ​

US Patent 9,283,365

Title: Patch production
Issued: 15 March 2016
Assignee: University of Queensland
Description:  This patent covers a method of coating bioactives onto projections from a patch.

US Patent 9,283,291

Title: Methods for radiolabeling macromolecules
Issued: 15 March 2016
Assignee: Australian National University
Description: This patent covers a new method of radiolabelling proteins that involves managing through pH the repulsive electrostatic forces that would ordinarily push radiolabel and protein apart.

US Patent 9,283,212

Title: Pharmaceutical preparation and delivery system
Issued: 15 March 2016
Assignee: Palmaya Pty Ltd (​Dr George O'Neil)
Description: This patent covers subcutaneous implant​s of flumazenil for the treatment of addictions.

US Patent 9,278,134

Title: Dual functioning ionic liquids and salts thereof
Issued: 8 March 2016
Assignee: Monash University (33%),​ University of Alabama (US, 33%), Queen's University Belfast (UK, 33%)
Description: This patent covers ionic liquids useful in pharmaceutical formulations.

US Patent 9,273,125

Title: Human monoclonal antibody having fat-reducing effect
Issued: 1 March 2016
Assignee: Patrys (ASX: PAB)
Description: This patent covers antibodies to LDL cholesterol.

US Patent 9,272,046

Title: Itraconazole compositions and dosage forms, and methods of using the same
Issued: 1 March 2016
Assignee: Mayne Pharma (ASX: MYX)
Description: This patent covers a new formulation of the antifungal drug itraconazole.

US Patent 9,271,982

Title: Animal feed supplement comprising ractopamine and caffeine
Issued: 1 March 2016
Assignee: Rivalea
Description: This patent covers a combination of ractipamine, a beta adrenergic agonist, and caffeine to improve feed conversion rates in pigs.

US Patent 9,271,503

Title: Control of insect pests
Issued: 1 March 2016
Assignee: Innovate Ag
Description: This patent covers compounds from Clitoria ternatea to control insect pests relevant to the cotton industry.

US Patent 9,268,908

Title: Computer systems for treating diseases
Issued: 23 February 2016
Assignee: Biotempus
Description: This patent covers software to analyse cell counts as a way to track immune system cycles for optimal chemotherapy.

US Patent 9,266,864

Title: VEGFR3 inhibitors
Issued: 23 February 2016
Assignee: Cancer Therapeutics CRC
Description: This patent covers small molecule antagonists to VEGFR3.

US Patent 9,265,817

Title: PAT-LM1 epitopes and methods for using same
Issued: 23 February 2016
Assignee: ​Patrys (ASX: PAB)
Description: This patent covers the target for PAT-LM1, a monoclonal antibody relevant in haematological malignancies, including lymphomas.

US Patent 9,265,726

Title: Foamable suspension gel 
Issued: 23 February 2016
Assignee: Stiefel Research Australia
Description: This patent covers a foamable gel for topical drug delivery. 

US Patent 9,265,249

Title: Dispersants in high-electrolyte solutions
Issued: 23 February 2016
Assignee: Huntsman Corporation Australia
Description: This patent covers polyaminoamide resins to disperse water-insoluble actives in an aqueous solution.

US Patent 9,260,691

Title: Methods relating to an attenuated mycoplasma
Issued: 16 February 2016
Assignee: Bioproperties Pty Ltd
Description: This patent covers the generation of attenuated Mycoplasma hyopneumoniae for use in porcine vaccines

US Patent 9,260,526

 Title: Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy
Issued: 16 February 2016
Assignee: Opthea (ASX: OPT)
Description: This patent covers the cancer target VEGFR-3 as well as antibodies to it.

US Patent 9,254,288

Title: Susceptibility of tumors to tyrosine kinase inhibitors and treatment thereof
Issued: 9 February 2016
Assignee: Queensland University of Technology (50%), The Translational Genomics Research Institute (US, 50%)
Description: This patent covers variants of the tyrosine kinase protein FGFR2, known to be relevant in cancer drug resistance

US Patent 9,247,766

Title: Angiogenin-enriched milk fractions
Issued: 2 February 2016
Assignee: Murray Goulburn Co-Operative (50%), Agriculture Victoria Services (50%) 
Description: This patent covers milk enriched for angiogenin, a peptide with anti-inflammatory and anti-microbial properties.

US Patent 9,243,066

Title: Use of M-CSF antibodies in the treatment of osteoarthritis or pain
Issued: 26 January 2016
Assignee: University of Melbourne (50%), MorphoSys (Germany, 50%)
Description: This patent covers antibodies for M-CSF, a hematopoietic growth factor, useful in the treatment of osteoarthritis.

US Patent 9,243,061

Title: Osteoarthritis treatment
Issued: 26 January 2016
Assignee: University of Melbourne
Description: This patent covers antibodies to GM-CSF, useful in tghe treatment of osteoarthritis, as well as GM-CSF knock-out mice.

US Patent 9,242,007

Title: Delivering functional nucleic acids to mammalian cells via bacterially-derived, intact minicells
Issued: 26 January 2016
Assignee:​ EnGeneIC
Description: This patent covers bacterially derived 'minicells' containing functional nucleic acids for use in cancer treatment

US Patent 9,241,952

Title: Method of treating type II diabetes, hyperglycemia or hypoglycemia by administering a synergistic combination of a sulphonylurea and inulin
Issued: 26 January 2016
Assignee: ​OzStar Therapeutics
Description: This patent covers a combination of the naturally occurring polysaccharide called inulin and a sulphonylurea in the treatment of Type II Diabetes.

US Patent 9,241,883

Title: Ionic complexes
Issued: 26 January 2016
Assignee: University of Melbourne
Description: This patent covers casein phosphopeptide formulations.

US Patent 9,239,904

Title: Computer systems for treating diseases
Issued: 19 January 2016
Assignee: Biotempus
Description: This patent covers software to analyse cell counts as a way to track immune system cycles for optimal chemotherapy.

US Patent 9,238,644

Title: VEGFR3 inhibitors
Issued: 19 January 2016
Assignee: Cancer Therapeutics CRC
Description: This patent covers small molecule antagonists to VEGFR3.

US Patent 9,238,054

Title: Treatment of kidney fibrosis with VIP fragments
Issued: 19 January 2016
Assignee: Vectus Biosystems (ASX: VBS)
Description: This patent covers the vasoactive intestinal peptide in the treatment of kidney disease.

US Patent 9,238,001

Title: Delivery system for remote treatment of an animal
Issued: 19 January 2016
Assignee: Smartvet Pty Ltd
 Description: This patent covers a gun to deliver doses to an animal remotely.

US Patent 9,234,019

Title: Modified Cpn10 and PRR signalling
Issued: 12 January 2016
Assignee: Invion (ASX: IVX)
Description: This patent covers chaperonin 10 polypeptides, useful for activating Toll-Like Receptors.

US Patent 9,226,939

Title: Histone inhibition
Issued: 5 January 2016
Assignee: Australian National University
Description: This patent covers polyanions  to combat the cytotoxic effects of extracellular histones in diseases such as sepsis.

US Patent 9,221,799

Title: Anti-cancer agents
Issued: 29 December 2015
Assignee: ​Walter and Eliza Hall Institute
Description:  This patent covers analogus of the marine alkaloid naamidine A, which is an antagonist of the Epidermal Growth Factor Receptor.

US Patent 9,220,928

Title: Plant extracts from Acronychia species and their use
Issued: 29 December 2015
Assignee: EcoBiotics
Description: This patent covers natural products derived from a rainforest treet native to north Queensland called the lemon aspen (Acronychia acidula).

US Patent 9,220,806

Title: Biocompatible material and uses thereof
Issued: 29 December 2015
Assignee: University of Sydney
Description: This patent covers a biocompatible ceramic made of doped calcium zinc silicate and a metal oxide useful in tissue regeneration. 

US Patent 9,220,724

Title: MicroRNA-based approach to treating malignant pleural mesothelioma​
Issued: 29 December 2015
Assignee: Asbestos Diseases Research Institute
Description: This patent covers microRNA mimics, corresponding to the miR-15/107 family potentially useful in the treatment of mesothelioma.

US Patent 9,220,678

Title: Coating method
Issued: 29 December 2015
Assignee: University of Queensland
Description: This patent covers a method of coating bioactives onto projections from a patch.

Copyright © 2016 NDF Research
Proudly powered by Weebly
  • Introducing NDF
  • About us
    • About our Senior Analyst
    • Disclaimer relating to research and web content
    • Financial Services Guide and General Advice Warning
  • What we do
    • The Rise of the New Analysts
    • MiFID II
  • Our sector
    • ASX-Listed Life Science companies we watch >
      • ASX-listed Life Science companies, >$200m
      • ASX-listed Life Science companies, $100-200m
    • About Australia and Australians
    • Australia and the Life Sciences
    • Life Sciences in New Zealand >
      • Building the New Zealand Life Sciences sector
    • A tour of Life Sciences Down Under
    • Australia's global competitiveness in Life Sciences >
      • Australia's Life Sciences Innovation Rating
      • Australia's Life Sciences clusters
      • Australia's World-Class Universities
      • Australia's Nobel Laureates
      • Australia's public policy support for Life Sciences
      • Australia's support for women in Life Sciences
    • The Coming Boom in Australian Life Sciences >
      • Welcome to Australia's Life Sciences Boom
    • Key organisations in the Life Science sector in Australia and New Zealand
    • Notable people in the Life Sciences sector in Australia and New Zealand >
      • Great CEOs
      • 2017 Red Hat Award Winners
      • 2018 Red Hat Award Winners
      • 2019 Red Hat Award Winners
    • The NDF Life Sciences Index >
      • 2016-2017 Year in Review
  • Our clients
  • Contact us
    • linkedin
    • Twitter
    • NDF Research Youtube Channel
  • Latest research
    • Comprehensive update reports
    • Shorter update reports
    • Initiation reports >
      • Admedus
      • Invion
    • Media and interviews
    • Presentations
    • Previous research and media, 2003-2015
    • A Brief History of the Life Sciences in Australia
    • In our library
    • Intellectual property >
      • Australian PCT patent applications
      • New Zealand PCT patent applications
      • PCT patent applications, last twelve months >
        • 2017 PCT patent applications
        • 2016 PCT patent applications
        • 2015 PCT patent applications
        • 2014 PCT patent applications
        • 2013 PCT patent applications
      • US patents >
        • 2017 US patents
        • 2016 US patents
        • 2015 US patents
        • 2014 US patents
    • Publications
    • Glossary
    • Global Life Science companies to watch
  • Blog